DH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Definitive Healthcare Corp (DH) is not a strong buy for a beginner investor with a long-term strategy. The stock shows weak financial performance, bearish technical indicators, and negative sentiment from analysts. With no recent positive catalysts or strong trading signals, it is better to hold off on investing in this stock at the moment.
The MACD is slightly positive and expanding, but RSI is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.026, with resistance at 1.105 and support at 0.948, indicating limited upward momentum.
No recent news or events that could act as positive catalysts. The MACD histogram is slightly positive, which may indicate minor short-term momentum.
Analysts have significantly lowered price targets, reflecting negative sentiment. Financial performance in Q4 2025 showed significant declines in revenue, net income, and EPS. Hedge funds and insiders show no significant trading activity, and there is no recent congress trading data. The stock's implied volatility is extremely high, indicating uncertainty.
In Q4 2025, revenue dropped by -1.21% YoY to $61.53M. Net income fell sharply by -84.23% YoY to -$9.32M. EPS dropped by -82.35% YoY to -0.09. Gross margin slightly decreased to 61.26%, down -0.08% YoY. Overall, the financials indicate a struggling business with declining profitability.
Analysts have lowered price targets significantly over the past month. Barclays recently reduced the price target to $1 from $2.75 with an Underweight rating. Other firms, such as Baird, Stephens, and Deutsche Bank, have also lowered targets, citing growth challenges and uncertain turnaround efforts. The sentiment is predominantly negative, with only one Buy rating from Stifel.
